Report overview
Inflammation of liver causes hepatitis. Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chronic hepatitis infection. Chronic hepatitis C is diagnosed by liver biopsy and blood tests.
This report aims to provide a comprehensive presentation of the global market for Hepatitis C Virus (HCV), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis C Virus (HCV). This report contains market size and forecasts of Hepatitis C Virus (HCV) in global, including the following market information:
Global Hepatitis C Virus (HCV) Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Hepatitis C Virus (HCV) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America dominates the global market for hepatitis C virus antiviral due to rising incidence of infectious diseases. Asia followed by the Europe are expected to show high growth rates in the next five years in global hepatitis C virus antiviral market. China and India are expected to be the fastest growing hepatitis C virus antiviral markets in Asia-Pacific region. Some of the key driving forces for hepatitis C virus antiviral market in emerging countries are large pool of patients, increasing awareness programs and rising government funding.
We surveyed the Hepatitis C Virus (HCV) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis C Virus (HCV) Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Hepatitis C Virus (HCV) Market Segment Percentages, by Type, 2022 (%)
Hepatitis C Drugs
Hepatitis C Test Kit
Global Hepatitis C Virus (HCV) Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Hepatitis C Virus (HCV) Market Segment Percentages, by Application, 2022 (%)
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Global Hepatitis C Virus (HCV) Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Hepatitis C Virus (HCV) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatitis C Virus (HCV) revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Hepatitis C Virus (HCV) revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Gilead
Merck
AbbVie
J&J
Bristol-Myers Squibb
Kawin
Abbott
Siemens Healthineers
Roche Diagnostics
altona Diagnostics
GeneProof
Sansure Biotech
Daan Gene
BGI Group
Abiores
ACON Biotech
Nectar Lifesciences
Everlywell
bioLytical
Liferiver
3B BlackBio Biotech India Limited
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hepatitis C Virus (HCV), market overview.
Chapter 2: Global Hepatitis C Virus (HCV) market size in revenue.
Chapter 3: Detailed analysis of Hepatitis C Virus (HCV) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hepatitis C Virus (HCV) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
